AIM: To elucidate how krüppel-like factor 4 (KLF4) activates mitofusin 2 (mfn-2) expression in all-trans retinoic acid (ATRA)-induced vascular smooth muscle cell (VSMC) differentiation. METHODS: The mfn-2 promoter-reporter constructs and the KLF4 acetylation-deficient or phosphorylation-deficient mutants were constructed. Adenoviral vector of KLF4-mediated overexpression and Western blot analysis were used to determine the effect of KLF4 on mfn-2 expression. The luciferase assay and chromatin immunoprecipitation were used to detect the transactivation of KLF4 on mfn-2 gene expression. Co-immunoprecipitation and GST pull-down assays were used to determine the modification of KLF4 and interaction of KLF4 with p300 in VSMCs. RESULTS: KLF4 mediated ATRA-induced mfn-2 expression in VSMCs. KLF4 bound directly to the mfn-2 promoter and activated its transcription. ATRA increased the interaction of KLF4 with p300 by inducing KLF4 phosphorylation via activation of JNK and p38 MAPK signaling. KLF4 acetylation by p300 increased its activity to transactivate the mfn-2 promoter. CONCLUSION: ATRA induces KLF4 acetylation by p300 and increases the ability of KLF4 to transactivate the mfn-2 promoter in VSMCs.
AIM: To elucidate how krüppel-like factor 4 (KLF4) activates mitofusin 2 (mfn-2) expression in all-trans retinoic acid (ATRA)-induced vascular smooth muscle cell (VSMC) differentiation. METHODS: The mfn-2 promoter-reporter constructs and the KLF4 acetylation-deficient or phosphorylation-deficient mutants were constructed. Adenoviral vector of KLF4-mediated overexpression and Western blot analysis were used to determine the effect of KLF4 on mfn-2 expression. The luciferase assay and chromatin immunoprecipitation were used to detect the transactivation of KLF4 on mfn-2 gene expression. Co-immunoprecipitation and GST pull-down assays were used to determine the modification of KLF4 and interaction of KLF4 with p300 in VSMCs. RESULTS:KLF4 mediated ATRA-induced mfn-2 expression in VSMCs. KLF4 bound directly to the mfn-2 promoter and activated its transcription. ATRA increased the interaction of KLF4 with p300 by inducing KLF4 phosphorylation via activation of JNK and p38 MAPK signaling. KLF4 acetylation by p300 increased its activity to transactivate the mfn-2 promoter. CONCLUSION:ATRA induces KLF4 acetylation by p300 and increases the ability of KLF4 to transactivate the mfn-2 promoter in VSMCs.
Authors: Sara Pich; Daniel Bach; Paz Briones; Marc Liesa; Marta Camps; Xavier Testar; Manuel Palacín; Antonio Zorzano Journal: Hum Mol Genet Date: 2005-04-13 Impact factor: 6.150
Authors: Brian F Hinnebusch; Aleem Siddique; J Welles Henderson; Madhu S Malo; Wenying Zhang; Christopher P Athaide; Mario A Abedrapo; Xinming Chen; Vincent W Yang; Richard A Hodin Journal: Am J Physiol Gastrointest Liver Physiol Date: 2003-08-14 Impact factor: 4.052
Authors: Michael B Steketee; Stavros N Moysidis; Jessica E Weinstein; Alex Kreymerman; Jose P Silva; Siraj Iqbal; Jeffrey L Goldberg Journal: Invest Ophthalmol Vis Sci Date: 2012-10-30 Impact factor: 4.799
Authors: Sandeep K Mallipattu; Sylvia J Horne; Vivette D'Agati; Goutham Narla; Ruijie Liu; Michael A Frohman; Kathleen Dickman; Edward Y Chen; Avi Ma'ayan; Agnieszka B Bialkowska; Amr M Ghaleb; Mandayam O Nandan; Mukesh K Jain; Ilse Daehn; Peter Y Chuang; Vincent W Yang; John C He Journal: J Clin Invest Date: 2015-02-17 Impact factor: 14.808
Authors: Andrew Henry Lewis; Cory Seth Bridges; David Neal Moorshead; Taylor J Chen; Wa Du; Barry Zorman; Pavel Sumazin; Monica Puppi; H Daniel Lacorazza Journal: Stem Cells Date: 2022-08-25 Impact factor: 5.845